Keensight Capital invests in AstraZeneca spin-out
The deal will boost CatSci’s ability to deliver best-in-class medicines to patients worldwide - News - PharmaTimes
Source: pharmatimes.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Keensight . Real-time updates on events, politics, business and more.